Zhen Chen
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Circular RNAs in diseases 11
- Oncology 95
- Pancreatic and Hepatic Oncology Research 20
- Inflammatory Biomarkers in Disease Prognosis 15
- Drug Transport and Resistance Mechanisms 13
- Co-authors
- Zhiqiang Meng (52 shared papers)Peng Wang (30 shared papers)Lianyu Chen (31 shared papers)Yawen Geng (10 shared papers)Qi Qi (8 shared papers)Luming Liu (18 shared papers)Shulin Yu (7 shared papers)Chien‐shan Cheng (28 shared papers)
- Journals
- Scientific Reports (8 papers)Oncotarget (7 papers)Frontiers in Oncology (6 papers)Integrative Cancer Therapies (6 papers)Evidence-based Complementary and Alternative Medicine (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhen Chen
446 papers receiving 11.4k citations
Zhen Chen's Hit Papers
Peers
Comparison fields: 5 of 174
- Cancer Research 2.0k
- Oncology 2.9k
- Immunology 1.0k
- Dermatology 413
- Complementary and alternative medicine 387
Countries citing papers authored by Zhen Chen
This map shows the geographic impact of Zhen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Chen more than expected).
Fields of papers citing papers by Zhen Chen
This network shows the impact of papers produced by Zhen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Chen. The network helps show where Zhen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 482 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy Hit paper breakdown → | 2016 | 473 |
| 2 | Defining Success After Surgery for Pelvic Organ Prolapse Hit paper breakdown → | 2009 | 387 |
| 3 | 2020 | 283 | |
| 4 | 2020 | 258 | |
| 5 | 2013 | 206 | |
| 6 | 2013 | 182 | |
| 7 | 2012 | 167 | |
| 8 | 2019 | 160 | |
| 9 | Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis Hit paper breakdown → | 2022 | 156 |
| 10 | 2014 | 138 | |
| 11 | 2019 | 137 | |
| 12 | 2012 | 133 | |
| 13 | 2013 | 129 | |
| 14 | 1998 | 123 | |
| 15 | 2021 | 118 | |
| 16 | 2018 | 111 | |
| 17 | 2018 | 108 | |
| 18 | 2015 | 107 | |
| 19 | 2015 | 107 | |
| 20 | 2021 | 107 |
About Zhen Chen
Zhen Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 482 papers that have together received 11.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Pancreatic and Hepatic Oncology Research (20 papers), Cancer-related molecular mechanisms research (18 papers), Inflammatory Biomarkers in Disease Prognosis (15 papers), Drug Transport and Resistance Mechanisms (13 papers), Dermatology and Skin Diseases (12 papers), Circular RNAs in diseases (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (11 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (2.9k citations), Immunology (1.0k citations), Dermatology (413 citations) and Complementary and alternative medicine (387 citations). Zhen Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhiqiang Meng, Peng Wang, Lianyu Chen, Yawen Geng, Qi Qi, Luming Liu, Shulin Yu, Chien‐shan Cheng, Luming Liu and Liping Zhuang. Their work appears in journals such as Scientific Reports, Oncotarget, Frontiers in Oncology, Integrative Cancer Therapies and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.